» Articles » PMID: 2947863

Induction of a Macrophage-suppressive Lymphokine by Soluble Cryptococcal Antigens and Its Association with Models of Immunologic Tolerance

Overview
Journal Infect Immun
Date 1987 Jan 1
PMID 2947863
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Soluble extracts of Cryptococcus neoformans were examined for their ability to induce a macrophage-regulatory T-suppressor cell known to appear in the spleens of mice infected with cryptococci. Suppressor cells were induced by injection of extracts of encapsulated or thinly encapsulated strains of cryptococci. Dose-response analysis showed that as little as 25 micrograms of soluble capsular polysaccharide antigen could induce significant suppressor cell activity, with maximum suppression occurring at a dose of 100 micrograms. The suppressor cells appeared within 1 week of injection of antigen and persisted for at least 2 months. Suppressor cells were induced in animals given tolerogenic doses of levan, human gamma globulin, and soluble capsular polysaccharide antigen. When these same antigens were administered in immunogenic form, no suppressor cell activity was detected. Therefore, the suppressive mechanism was common to models of immunologic tolerance and was not unique to cryptococcal disease or cryptococcal capsular polysaccharide antigen. The phagocytosis-inhibiting lymphokine produced by the suppressor cell population completely inhibited the phagocytic activity of only a portion of peritoneal exudate cells. Other macrophages in the population were not totally inhibited but exhibited a reduction in the number of yeast cells engulfed.

Citing Articles

The capsule of the fungal pathogen Cryptococcus neoformans.

Zaragoza O, Rodrigues M, De Jesus M, Frases S, Dadachova E, Casadevall A Adv Appl Microbiol. 2009; 68:133-216.

PMID: 19426855 PMC: 2739887. DOI: 10.1016/S0065-2164(09)01204-0.


Immunosuppression, interleukin-10 synthesis and apoptosis are induced in rats inoculated with Cryptococcus neoformans glucuronoxylomannan.

Chiapello L, Baronetti J, Aoki M, Gea S, Rubinstein H, Masih D Immunology. 2004; 113(3):392-400.

PMID: 15500627 PMC: 1782585. DOI: 10.1111/j.1365-2567.2004.01970.x.


Roles for CD40, B7 and major histocompatibility complex in induction of enhanced immunity by cryptococcal polysaccharide-pulsed antigen-presenting cells.

Blackstock R Immunology. 2003; 108(2):158-66.

PMID: 12562324 PMC: 1782881. DOI: 10.1046/j.1365-2567.2003.01574.x.


Regulation of cytokine expression in mice immunized with cryptococcal polysaccharide, a glucuronoxylomannan (GXM), associated with peritoneal antigen-presenting cells (APC): requirements for GXM, APC activation, and interleukin-12.

Blackstock R, McElwee N, Neller E Infect Immun. 2000; 68(9):5146-53.

PMID: 10948138 PMC: 101763. DOI: 10.1128/IAI.68.9.5146-5153.2000.


Cytokine involvement in immunomodulatory activity affected by Candida albicans mannan.

Wang Y, Li S, Moser S, Bost K, Domer J Infect Immun. 1998; 66(4):1384-91.

PMID: 9529057 PMC: 108064. DOI: 10.1128/IAI.66.4.1384-1391.1998.


References
1.
Murphy J, COZAD G . Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique. Infect Immun. 1972; 5(6):896-901. PMC: 422459. DOI: 10.1128/iai.5.6.896-901.1972. View

2.
Bulmer G, Sans M . Cryptococcus neoformans. II. Phagocytosis by human leukocytes. J Bacteriol. 1967; 94(5):1480-3. PMC: 276851. DOI: 10.1128/jb.94.5.1480-1483.1967. View

3.
Dorf M, Benacerraf B . Suppressor cells and immunoregulation. Annu Rev Immunol. 1984; 2:127-57. DOI: 10.1146/annurev.iy.02.040184.001015. View

4.
Johnson H, Brenner K, Hall H . The use of a wate-soluble carbodiimide as a coupling reagent in the passive hemagglutination test. J Immunol. 1966; 97(6):791-6. View

5.
Murphy J, Mosley R . Regulation of cell-mediated immunity in cryptococcosis. III. Characterization of second-order T suppressor cells (Ts2). J Immunol. 1985; 134(1):577-84. View